How many patents does
Chdi Foundation have?
patents
427
families
29
granted
58
applications
369
US
75
EP
58
WO
31
JP
27
CN
20
KR
16
RoW
200
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Chdi Foundation
Top ten assignees appearing on patents
2009 - 2018
| isis pharmaceuticals | 24 |
| chdi | 12 |
| ionis pharmaceuticals | 11 |
| sangamo biosciences | 8 |
| kiselyov, alex | 6 |
| chdi fountain | 1 |
| chidi | 1 |
| hdi management | 1 |
| sangamo therapeutics | 1 |
2009
Chdi Foundation
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use t… 🛈 | 48 | 2011 |
| compositions and their uses directed to huntingtin | 38 | 2006 |
| certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods … 🛈 | 24 | 2008 |
| kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use t… 🛈 | 22 | 2012 |
| certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods … 🛈 | 20 | 2011 |
| methods and compositions for treating hiv-related disorders | 19 | 2014 |
| kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use t… 🛈 | 19 | 2011 |
| histone deacetylase inhibitors and compositions and methods of use thereof | 19 | 2012 |
| histone deacetylase inhibitors and compositions and methods of use thereof | 16 | 2011 |
| certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods … 🛈 | 16 | 2010 |